REPORT ID 7137

Global Histone Deacetylase(HDAC) Inhibitors Market Research Report 2017

Publish Date
2-Nov-17
Pages
113
Format
Electronic (PDF)

In this report, the global Histone Deacetylase(HDAC) Inhibitors market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Histone Deacetylase(HDAC) Inhibitors in these regions, from 2012 to 2022 (forecast), covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Global Histone Deacetylase(HDAC) Inhibitors market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    Gloucester Pharmaceuticals
    Spectrum Pharmaceuticals
    Pharmacyclics
    Ventana Medical Systems
    Signal Rx
    SpeBio
    Quimatryx
    TetraLogic Pharmaceuticals
    Onyx
    Mirati Therapeutics
    Karus Therapeutics
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Hydroxamic Acids
    Cyclic Tetrapeptides
    Benzamides
    Electrophilic Ketones
    Aliphatic Acid
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
    Psychiatry and Neurology
    Cancer Treatment
    HIV
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Histone Deacetylase(HDAC) Inhibitors Market Research Report 2017
1 Histone Deacetylase(HDAC) Inhibitors Market Overview
    1.1 Product Overview and Scope of Histone Deacetylase(HDAC) Inhibitors
    1.2 Histone Deacetylase(HDAC) Inhibitors Segment by Type (Product Category)
        1.2.1 Global Histone Deacetylase(HDAC) Inhibitors Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
        1.2.2 Global Histone Deacetylase(HDAC) Inhibitors Production Market Share by Type (Product Category) in 2016
        1.2.3 Hydroxamic Acids
        1.2.4 Cyclic Tetrapeptides
        1.2.5 Benzamides
        1.2.6 Electrophilic Ketones
        1.2.7 Aliphatic Acid
    1.3 Global Histone Deacetylase(HDAC) Inhibitors Segment by Application
        1.3.1 Histone Deacetylase(HDAC) Inhibitors Consumption (Sales) Comparison by Application (2012-2022)
        1.3.2 Psychiatry and Neurology
        1.3.3 Cancer Treatment
        1.3.4 HIV
        1.3.5 Others
    1.4 Global Histone Deacetylase(HDAC) Inhibitors Market by Region (2012-2022)
        1.4.1 Global Histone Deacetylase(HDAC) Inhibitors Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
        1.4.2 North America Status and Prospect (2012-2022)
        1.4.3 Europe Status and Prospect (2012-2022)
        1.4.4 China Status and Prospect (2012-2022)
        1.4.5 Japan Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Status and Prospect (2012-2022)
        1.4.7 India Status and Prospect (2012-2022)
    1.5 Global Market Size (Value) of Histone Deacetylase(HDAC) Inhibitors (2012-2022)
        1.5.1 Global Histone Deacetylase(HDAC) Inhibitors Revenue Status and Outlook (2012-2022)
        1.5.2 Global Histone Deacetylase(HDAC) Inhibitors Capacity, Production Status and Outlook (2012-2022)

2 Global Histone Deacetylase(HDAC) Inhibitors Market Competition by Manufacturers
    2.1 Global Histone Deacetylase(HDAC) Inhibitors Capacity, Production and Share by Manufacturers (2012-2017)
        2.1.1 Global Histone Deacetylase(HDAC) Inhibitors Capacity and Share by Manufacturers (2012-2017)
        2.1.2 Global Histone Deacetylase(HDAC) Inhibitors Production and Share by Manufacturers (2012-2017)
    2.2 Global Histone Deacetylase(HDAC) Inhibitors Revenue and Share by Manufacturers (2012-2017)
    2.3 Global Histone Deacetylase(HDAC) Inhibitors Average Price by Manufacturers (2012-2017)
    2.4 Manufacturers Histone Deacetylase(HDAC) Inhibitors Manufacturing Base Distribution, Sales Area and Product Type
    2.5 Histone Deacetylase(HDAC) Inhibitors Market Competitive Situation and Trends
        2.5.1 Histone Deacetylase(HDAC) Inhibitors Market Concentration Rate
        2.5.2 Histone Deacetylase(HDAC) Inhibitors Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Histone Deacetylase(HDAC) Inhibitors Capacity, Production, Revenue (Value) by Region (2012-2017)
    3.1 Global Histone Deacetylase(HDAC) Inhibitors Capacity and Market Share by Region (2012-2017)
    3.2 Global Histone Deacetylase(HDAC) Inhibitors Production and Market Share by Region (2012-2017)
    3.3 Global Histone Deacetylase(HDAC) Inhibitors Revenue (Value) and Market Share by Region (2012-2017)
    3.4 Global Histone Deacetylase(HDAC) Inhibitors Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.5 North America Histone Deacetylase(HDAC) Inhibitors Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.6 Europe Histone Deacetylase(HDAC) Inhibitors Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.7 China Histone Deacetylase(HDAC) Inhibitors Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.8 Japan Histone Deacetylase(HDAC) Inhibitors Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.9 Southeast Asia Histone Deacetylase(HDAC) Inhibitors Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.10 India Histone Deacetylase(HDAC) Inhibitors Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Histone Deacetylase(HDAC) Inhibitors Supply (Production), Consumption, Export, Import by Region (2012-2017)
    4.1 Global Histone Deacetylase(HDAC) Inhibitors Consumption by Region (2012-2017)
    4.2 North America Histone Deacetylase(HDAC) Inhibitors Production, Consumption, Export, Import (2012-2017)
    4.3 Europe Histone Deacetylase(HDAC) Inhibitors Production, Consumption, Export, Import (2012-2017)
    4.4 China Histone Deacetylase(HDAC) Inhibitors Production, Consumption, Export, Import (2012-2017)
    4.5 Japan Histone Deacetylase(HDAC) Inhibitors Production, Consumption, Export, Import (2012-2017)
    4.6 Southeast Asia Histone Deacetylase(HDAC) Inhibitors Production, Consumption, Export, Import (2012-2017)
    4.7 India Histone Deacetylase(HDAC) Inhibitors Production, Consumption, Export, Import (2012-2017)

5 Global Histone Deacetylase(HDAC) Inhibitors Production, Revenue (Value), Price Trend by Type
    5.1 Global Histone Deacetylase(HDAC) Inhibitors Production and Market Share by Type (2012-2017)
    5.2 Global Histone Deacetylase(HDAC) Inhibitors Revenue and Market Share by Type (2012-2017)
    5.3 Global Histone Deacetylase(HDAC) Inhibitors Price by Type (2012-2017)
    5.4 Global Histone Deacetylase(HDAC) Inhibitors Production Growth by Type (2012-2017)

6 Global Histone Deacetylase(HDAC) Inhibitors Market Analysis by Application
    6.1 Global Histone Deacetylase(HDAC) Inhibitors Consumption and Market Share by Application (2012-2017)
    6.2 Global Histone Deacetylase(HDAC) Inhibitors Consumption Growth Rate by Application (2012-2017)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global Histone Deacetylase(HDAC) Inhibitors Manufacturers Profiles/Analysis
    7.1 Gloucester Pharmaceuticals
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 Histone Deacetylase(HDAC) Inhibitors Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 Gloucester Pharmaceuticals Histone Deacetylase(HDAC) Inhibitors Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.1.4 Main Business/Business Overview
    7.2 Spectrum Pharmaceuticals
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 Histone Deacetylase(HDAC) Inhibitors Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 Spectrum Pharmaceuticals Histone Deacetylase(HDAC) Inhibitors Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.2.4 Main Business/Business Overview
    7.3 Pharmacyclics
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 Histone Deacetylase(HDAC) Inhibitors Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 Pharmacyclics Histone Deacetylase(HDAC) Inhibitors Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.3.4 Main Business/Business Overview
    7.4 Ventana Medical Systems
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 Histone Deacetylase(HDAC) Inhibitors Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 Ventana Medical Systems Histone Deacetylase(HDAC) Inhibitors Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.4.4 Main Business/Business Overview
    7.5 Signal Rx
        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.5.2 Histone Deacetylase(HDAC) Inhibitors Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 Signal Rx Histone Deacetylase(HDAC) Inhibitors Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.5.4 Main Business/Business Overview
    7.6 SpeBio
        7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.6.2 Histone Deacetylase(HDAC) Inhibitors Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 SpeBio Histone Deacetylase(HDAC) Inhibitors Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.6.4 Main Business/Business Overview
    7.7 Quimatryx
        7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.7.2 Histone Deacetylase(HDAC) Inhibitors Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 Quimatryx Histone Deacetylase(HDAC) Inhibitors Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.7.4 Main Business/Business Overview
    7.8 TetraLogic Pharmaceuticals
        7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.8.2 Histone Deacetylase(HDAC) Inhibitors Product Category, Application and Specification
            7.8.2.1 Product A
            7.8.2.2 Product B
        7.8.3 TetraLogic Pharmaceuticals Histone Deacetylase(HDAC) Inhibitors Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.8.4 Main Business/Business Overview
    7.9 Onyx
        7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.9.2 Histone Deacetylase(HDAC) Inhibitors Product Category, Application and Specification
            7.9.2.1 Product A
            7.9.2.2 Product B
        7.9.3 Onyx Histone Deacetylase(HDAC) Inhibitors Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.9.4 Main Business/Business Overview
    7.10 Mirati Therapeutics
        7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.10.2 Histone Deacetylase(HDAC) Inhibitors Product Category, Application and Specification
            7.10.2.1 Product A
            7.10.2.2 Product B
        7.10.3 Mirati Therapeutics Histone Deacetylase(HDAC) Inhibitors Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.10.4 Main Business/Business Overview
    7.11 Karus Therapeutics

8 Histone Deacetylase(HDAC) Inhibitors Manufacturing Cost Analysis
    8.1 Histone Deacetylase(HDAC) Inhibitors Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Histone Deacetylase(HDAC) Inhibitors

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Histone Deacetylase(HDAC) Inhibitors Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Histone Deacetylase(HDAC) Inhibitors Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global Histone Deacetylase(HDAC) Inhibitors Market Forecast (2017-2022)
    12.1 Global Histone Deacetylase(HDAC) Inhibitors Capacity, Production, Revenue Forecast (2017-2022)
        12.1.1 Global Histone Deacetylase(HDAC) Inhibitors Capacity, Production and Growth Rate Forecast (2017-2022)
        12.1.2 Global Histone Deacetylase(HDAC) Inhibitors Revenue and Growth Rate Forecast (2017-2022)
        12.1.3 Global Histone Deacetylase(HDAC) Inhibitors Price and Trend Forecast (2017-2022)
    12.2 Global Histone Deacetylase(HDAC) Inhibitors Production, Consumption , Import and Export Forecast by Region (2017-2022)
        12.2.1 North America Histone Deacetylase(HDAC) Inhibitors Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.2 Europe Histone Deacetylase(HDAC) Inhibitors Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.3 China Histone Deacetylase(HDAC) Inhibitors Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.4 Japan Histone Deacetylase(HDAC) Inhibitors Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.5 Southeast Asia Histone Deacetylase(HDAC) Inhibitors Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.6 India Histone Deacetylase(HDAC) Inhibitors Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
    12.3 Global Histone Deacetylase(HDAC) Inhibitors Production, Revenue and Price Forecast by Type (2017-2022)
    12.4 Global Histone Deacetylase(HDAC) Inhibitors Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology/Research Approach
        14.1.1 Research Programs/Design
        14.1.2 Market Size Estimation
        14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
        14.2.1 Secondary Sources
        14.2.2 Primary Sources
    14.3 Disclaimer